Increasing brachytherapy dose predicts survival for interstitial and tandem-based radiation for stage IIIB cervical cancer

International Journal of Gynecological Cancer

Volumn 19, Issue 8, 2009, Pages 1402-1406

  Viswanathan, Akila N ^a   Cormack, Robert ^a   Rawal, Bhupendra ^b   Lee, Hang ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Brachytherapy; Cervical cancer; Interstitial; Stage IIIB; Tandem

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

ADENOCARCINOMA; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 73349128736     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181b62e73     Document Type: Article

References (24)

1. American Cancer Society. Cancer Facts & Figures 2007. Atlanta, Ga: American Cancer Society; 2007.
2. Carcinoma of the cervix uteri. In: Pettersson F, ed. Annual Report on the Results of Treatment in Gynecological Cancer FIGO 1988. Stockholm, Sweden: Radiumhemmet; 1988:29-34.
3. Logsdon MD, Eifel PJ. FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys. 1999;43:763-775.
4. Eifel PJ, Winter K, Morris M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol. 2004;22:872-880. (Pubitemid 41103599)
5. Montana GS, Fowler WC, Varia MA, et al. Carcinoma of the cervix, stage III. Results of radiation therapy. Cancer. 1986;57:148-154.
6. Lanciano RM, Martz K, Coia LR, et al. Tumor and treatment factors improving outcome in stage III-B cervix cancer. Int J Rad Oncol Biol Phys. 1991;20:95-100.
7. Hughes-Davies L, Silver B, Kapp D. Parametrial interstitial brachytherapy for advanced or recurrent pelvic malignancy: the Harvard/Stanford experience. Gynecol Oncol. 1995;58:24-27.
8. Gupta AK, Vicini FA, Frazier AJ, et al. Iridium-192 transperineal interstitial brachytherapy for locally advanced or recurrent gynecological malignancies. Int J Radiat Oncol Biol Phys. 1999;43:1055-1060.
9. Syed AM, Puthawala AA, Abdelaziz NN, et al. Long-term results of lowYdose-rate interstitial-intracavitary brachytherapy in the treatment of carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2002;54: 67-78.
10. Gaddis O Jr, Morrow CP, Klement V, et al. Treatment of cervical carcinoma employing a template for transperineal interstitial Ir192 brachytherapy. Int J Radiat Oncol Biol Phys. 1983;9:819-827.
11. Prempree T. Parametrial implant in stage III B cancer of the cervix. III. A five-year study. Cancer. 1983;52:748-750.
12. Agrawal PP, Singhal SS, Neema JP, et al. The role of interstitial brachytherapy using template in locally advanced gynecological malignancies. Gynecol Oncol. 2005;99:169-175.
13. Corn BW, Hanlon AL, Pajak TF, et al. Technically accurate intracavitary insertions improve pelvic control and survival among patients with locally advanced carcinoma of the uterine cervix. Gynecol Oncol. 1994;53:294-300.
14. Martinez A, Cox RS, Edmundson GK. A multiple-site perineal applicator (MUPIT) for treatment of prostatic, anorectal, and gynecologic malignancies. Int J Radiat Oncol Biol Phys. 1984;10: 297-305.
15. Syed AMN, Puthwala AA, Neblett D, et al. Transperineal interstitial-intracavitary BSyed-Neblett[ applicator in the treatment of carcinoma of the uterine cervix. Endocuriether Hyperther Oncol. 1986;2:1-13.
16. Erickson B, Eifel P, Moughan J, et al. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study. Int J Radiat Oncol Biol Phys. 2005;63:1083-1092.
17. Aristizabal SA, Surwit EA, Hevezi JM, et al. Treatment of advanced cancer of the cervix with transperineal interstitial irradiation. Int J Radiat Oncol Biol Phys. 1983;9:1013-1017.
18. Monk BJ, Tewari K, Burger RA, et al. A comparison of intracavitary versus interstitial irradiation in the treatment of cervical cancer. Gynecol Oncol. 1997;67:241-247.
19. Yeung AR, Amdur RJ, Morris CG, et al. Long-term outcome after radiotherapy for FIGO stage IIIB and IVA carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2007;67:1445-1450.
20. Saibishkumar EP, Patel FD, Sharma SC, et al. Prognostic value of response to external radiation in stage IIIB cancer cervix in predicting clinical outcomes: a retrospective analysis of 556 patients from India. Radiother Oncol. 2006;79:142-146.
21. Holloway CL, Racine ML, O'Farrell DA, et al. Sigmoid Dose Using 3D Imaging in Cervical Cancer Brachytherapy. Radioth Oncol. 2009, in press.
22. Viswanathan AN, Dimopoulos J, Kirisits C, et al. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys. 2007;68:491-498.
23. Lee LJ, Sadow CA, Russell AH, Viswanathan AN. Correlation of Point B and Lymph Node Dose in 3D-Planned High-Dose-Rate Cervical Cancer Brachytherapy. Int J Radiat Oncol Biol Phys. Epub 13 Mar 2009.
24. Montana GS, Martz KL, Hanks GE. Patterns and sites of failure in cervix cancer treated in the U.S.A. in 1978. Int J Radiat Oncol Biol Phys. 1991;20:87-93.